Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxb8
|
ENSMUSG00000056648.4 | homeobox B8 |
Pdx1
|
ENSMUSG00000029644.6 | pancreatic and duodenal homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_96282910_96285155 | Hoxb8 | 1307 | 0.193494 | 0.62 | 9.9e-08 | Click! |
chr11_96282037_96282248 | Hoxb8 | 237 | 0.800751 | 0.60 | 4.4e-07 | Click! |
chr11_96277191_96278406 | Hoxb8 | 4107 | 0.081987 | 0.59 | 7.5e-07 | Click! |
chr11_96279294_96280222 | Hoxb8 | 2147 | 0.121671 | 0.58 | 1.1e-06 | Click! |
chr11_96282426_96282794 | Hoxb8 | 54 | 0.924406 | 0.56 | 3.5e-06 | Click! |
chr5_147262244_147262395 | Pdx1 | 7640 | 0.113733 | 0.28 | 3.1e-02 | Click! |
chr5_147269788_147270699 | Pdx1 | 284 | 0.732766 | 0.21 | 1.1e-01 | Click! |
chr5_147235974_147236125 | Pdx1 | 33910 | 0.089100 | 0.18 | 1.7e-01 | Click! |
chr5_147262539_147262690 | Pdx1 | 7345 | 0.114252 | 0.18 | 1.7e-01 | Click! |
chr5_147250668_147250819 | Pdx1 | 19216 | 0.104268 | -0.08 | 5.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_52164011_52165366 | 7.88 |
Hoxa2 |
homeobox A2 |
143 |
0.83 |
chr10_102513522_102514467 | 6.00 |
Rassf9 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
1738 |
0.36 |
chr6_92533537_92534212 | 3.88 |
Prickle2 |
prickle planar cell polarity protein 2 |
987 |
0.63 |
chr2_64092860_64093848 | 3.74 |
Fign |
fidgetin |
4634 |
0.37 |
chr16_73869523_73869996 | 3.51 |
Robo2 |
roundabout guidance receptor 2 |
30126 |
0.23 |
chr11_96323074_96323798 | 3.37 |
Hoxb3 |
homeobox B3 |
110 |
0.9 |
chr17_43360343_43362046 | 3.32 |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
743 |
0.75 |
chr10_22813360_22814229 | 3.29 |
Gm10824 |
predicted gene 10824 |
1955 |
0.28 |
chr3_30009457_30010152 | 3.27 |
Mecom |
MDS1 and EVI1 complex locus |
1635 |
0.36 |
chr2_74734325_74737080 | 3.00 |
Hoxd3 |
homeobox D3 |
813 |
0.31 |
chr7_36707245_36708940 | 2.96 |
Gm37452 |
predicted gene, 37452 |
2082 |
0.23 |
chr16_85169623_85170249 | 2.96 |
Gm27295 |
predicted gene, 27295 |
1087 |
0.49 |
chr5_57721137_57722906 | 2.95 |
Pcdh7 |
protocadherin 7 |
108 |
0.94 |
chr19_36735347_36735508 | 2.87 |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
1226 |
0.51 |
chr1_178531534_178532270 | 2.85 |
Kif26b |
kinesin family member 26B |
2777 |
0.33 |
chr17_75435976_75437284 | 2.83 |
Rasgrp3 |
RAS, guanyl releasing protein 3 |
704 |
0.77 |
chr5_98169190_98169341 | 2.82 |
Prdm8 |
PR domain containing 8 |
2067 |
0.29 |
chr8_26438640_26439210 | 2.80 |
Gm45580 |
predicted gene 45580 |
96 |
0.96 |
chr10_41292796_41293533 | 2.79 |
Fig4 |
FIG4 phosphoinositide 5-phosphatase |
10096 |
0.16 |
chr2_126034531_126036034 | 2.76 |
Fgf7 |
fibroblast growth factor 7 |
309 |
0.93 |
chr8_11311242_11311393 | 2.76 |
Col4a1 |
collagen, type IV, alpha 1 |
1372 |
0.31 |
chr8_124990881_124991137 | 2.74 |
Tsnax |
translin-associated factor X |
21988 |
0.13 |
chr14_21903607_21905272 | 2.70 |
4931407E12Rik |
RIKEN cDNA 4931407E12 gene |
14673 |
0.14 |
chr2_74681971_74682670 | 2.68 |
Hoxd11 |
homeobox D11 |
3 |
0.9 |
chr10_22815720_22817074 | 2.66 |
Gm10824 |
predicted gene 10824 |
648 |
0.66 |
chr14_26441045_26441600 | 2.63 |
Slmap |
sarcolemma associated protein |
1333 |
0.39 |
chr1_14308374_14310407 | 2.59 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
446 |
0.88 |
chr6_140888560_140888983 | 2.58 |
Gm30524 |
predicted gene, 30524 |
66838 |
0.11 |
chr7_48847211_48847926 | 2.53 |
Csrp3 |
cysteine and glycine-rich protein 3 |
465 |
0.76 |
chr3_10206707_10207467 | 2.52 |
Fabp4 |
fatty acid binding protein 4, adipocyte |
1471 |
0.24 |
chr1_75015801_75016335 | 2.50 |
Nhej1 |
non-homologous end joining factor 1 |
30571 |
0.11 |
chr2_95232237_95232956 | 2.46 |
Gm13794 |
predicted gene 13794 |
161646 |
0.04 |
chr6_96113911_96115198 | 2.45 |
Tafa1 |
TAFA chemokine like family member 1 |
95 |
0.98 |
chr17_26844031_26845183 | 2.43 |
Nkx2-5 |
NK2 homeobox 5 |
402 |
0.75 |
chr6_52208128_52210195 | 2.42 |
Hoxa6 |
homeobox A6 |
439 |
0.52 |
chr1_168426195_168428871 | 2.40 |
Pbx1 |
pre B cell leukemia homeobox 1 |
3971 |
0.3 |
chr11_96334278_96335532 | 2.37 |
Hoxb3 |
homeobox B3 |
6040 |
0.08 |
chr3_123233703_123235038 | 2.37 |
Synpo2 |
synaptopodin 2 |
1726 |
0.3 |
chr3_37642054_37642205 | 2.36 |
Gm42922 |
predicted gene 42922 |
1473 |
0.23 |
chr2_169636158_169637469 | 2.30 |
Tshz2 |
teashirt zinc finger family member 2 |
3137 |
0.27 |
chr2_45001616_45002114 | 2.28 |
Zeb2 |
zinc finger E-box binding homeobox 2 |
21050 |
0.19 |
chr16_37779366_37779517 | 2.27 |
Fstl1 |
follistatin-like 1 |
2289 |
0.31 |
chr15_96165092_96165362 | 2.25 |
4833422M21Rik |
RIKEN cDNA 4833422M21 gene |
76562 |
0.09 |
chr11_96253803_96254020 | 2.24 |
Gm53 |
predicted gene 53 |
1379 |
0.21 |
chr1_168598116_168598755 | 2.22 |
1700063I16Rik |
RIKEN cDNA 1700063I16 gene |
77447 |
0.11 |
chr11_96331807_96334248 | 2.19 |
Hoxb3 |
homeobox B3 |
4965 |
0.08 |
chr5_120454576_120454844 | 2.18 |
Sdsl |
serine dehydratase-like |
12650 |
0.11 |
chr11_18872620_18872876 | 2.14 |
8430419K02Rik |
RIKEN cDNA 8430419K02 gene |
593 |
0.71 |
chr12_31711839_31712627 | 2.13 |
Gpr22 |
G protein-coupled receptor 22 |
1693 |
0.32 |
chr15_92441686_92442277 | 2.12 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
44680 |
0.19 |
chr16_37780797_37781371 | 2.11 |
Fstl1 |
follistatin-like 1 |
3932 |
0.23 |
chr19_44758783_44762005 | 2.10 |
Pax2 |
paired box 2 |
479 |
0.75 |
chr11_54904864_54905157 | 2.09 |
Gpx3 |
glutathione peroxidase 3 |
2084 |
0.24 |
chr12_31713469_31714088 | 2.09 |
Gpr22 |
G protein-coupled receptor 22 |
148 |
0.95 |
chr10_14017752_14018957 | 2.09 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
51330 |
0.13 |
chr5_138608490_138608879 | 2.07 |
Zfp68 |
zinc finger protein 68 |
1627 |
0.2 |
chr5_138609015_138609166 | 2.07 |
Gm15497 |
predicted gene 15497 |
1649 |
0.2 |
chrX_21484558_21485279 | 2.03 |
Agtr2 |
angiotensin II receptor, type 2 |
196 |
0.94 |
chr6_52160071_52161455 | 2.02 |
Hotairm1 |
Hoxa transcript antisense RNA, myeloid-specific 1 |
2239 |
0.09 |
chr15_101411658_101413570 | 2.01 |
Krt7 |
keratin 7 |
165 |
0.64 |
chr10_88604913_88605316 | 2.01 |
Mybpc1 |
myosin binding protein C, slow-type |
38 |
0.96 |
chr11_96328165_96328613 | 2.01 |
Hoxb3 |
homeobox B3 |
327 |
0.72 |
chr2_74732545_74733279 | 2.01 |
Hoxd3 |
homeobox D3 |
1 |
0.92 |
chr13_71960720_71961584 | 2.00 |
Irx1 |
Iroquois homeobox 1 |
436 |
0.87 |
chr4_13265765_13266082 | 1.98 |
Gm26250 |
predicted gene, 26250 |
1127 |
0.66 |
chr2_116056837_116059755 | 1.97 |
Meis2 |
Meis homeobox 2 |
546 |
0.75 |
chr3_125403648_125404947 | 1.97 |
Ndst4 |
N-deacetylase/N-sulfotransferase (heparin glucosaminyl) 4 |
207 |
0.97 |
chr10_5287995_5289689 | 1.97 |
Gm23573 |
predicted gene, 23573 |
68331 |
0.12 |
chr15_92598307_92599654 | 1.95 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
1854 |
0.49 |
chr1_62647919_62648262 | 1.95 |
Gm11600 |
predicted gene 11600 |
9698 |
0.18 |
chr10_118676040_118676569 | 1.94 |
Gm33337 |
predicted gene, 33337 |
39422 |
0.14 |
chr7_27331731_27331936 | 1.93 |
Ltbp4 |
latent transforming growth factor beta binding protein 4 |
1780 |
0.22 |
chr3_121725533_121726147 | 1.93 |
F3 |
coagulation factor III |
2270 |
0.16 |
chr5_43663282_43663726 | 1.92 |
Cc2d2a |
coiled-coil and C2 domain containing 2A |
1158 |
0.47 |
chr11_100394864_100395998 | 1.91 |
Jup |
junction plakoglobin |
2318 |
0.13 |
chr2_137112378_137113208 | 1.91 |
Jag1 |
jagged 1 |
3851 |
0.33 |
chr2_115510507_115510658 | 1.90 |
3110099E03Rik |
RIKEN cDNA 3110099E03 gene |
1619 |
0.47 |
chr8_114770688_114771203 | 1.90 |
Wwox |
WW domain-containing oxidoreductase |
58778 |
0.14 |
chr5_119676904_119677966 | 1.89 |
Tbx3 |
T-box 3 |
1990 |
0.25 |
chr6_117407362_117407846 | 1.89 |
Gm4640 |
predicted gene 4640 |
16013 |
0.22 |
chr4_102588865_102590254 | 1.89 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
164 |
0.97 |
chr2_121610263_121610569 | 1.84 |
Frmd5 |
FERM domain containing 5 |
23983 |
0.15 |
chr14_21988836_21990385 | 1.84 |
Zfp503 |
zinc finger protein 503 |
9 |
0.97 |
chr2_74745819_74748448 | 1.83 |
Hoxd3 |
homeobox D3 |
1411 |
0.17 |
chr6_21822751_21823961 | 1.82 |
Tspan12 |
tetraspanin 12 |
28472 |
0.16 |
chr3_30514092_30514862 | 1.82 |
Mecom |
MDS1 and EVI1 complex locus |
4655 |
0.16 |
chr7_49907312_49908741 | 1.81 |
Slc6a5 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 5 |
2120 |
0.4 |
chr11_96273839_96274152 | 1.81 |
Hoxb9 |
homeobox B9 |
2472 |
0.11 |
chr14_21988628_21988808 | 1.80 |
Zfp503 |
zinc finger protein 503 |
883 |
0.5 |
chr4_154630838_154632339 | 1.80 |
Prdm16 |
PR domain containing 16 |
5209 |
0.14 |
chr13_63244256_63244938 | 1.80 |
Gm47586 |
predicted gene, 47586 |
376 |
0.74 |
chr19_34253411_34255499 | 1.79 |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
225 |
0.92 |
chr9_73967774_73969221 | 1.79 |
Unc13c |
unc-13 homolog C |
469 |
0.88 |
chr10_41294785_41295025 | 1.78 |
Fig4 |
FIG4 phosphoinositide 5-phosphatase |
8355 |
0.16 |
chr6_52224853_52226609 | 1.78 |
Hoxa9 |
homeobox A9 |
458 |
0.51 |
chr1_17601856_17602960 | 1.77 |
Pi15 |
peptidase inhibitor 15 |
507 |
0.82 |
chr9_63150111_63150461 | 1.77 |
Skor1 |
SKI family transcriptional corepressor 1 |
1325 |
0.43 |
chr19_10769893_10770044 | 1.77 |
A430093F15Rik |
RIKEN cDNA A430093F15 gene |
11947 |
0.12 |
chr19_58627631_58627859 | 1.77 |
1810007D17Rik |
RIKEN cDNA 1810007D17 gene |
21416 |
0.16 |
chr5_150261018_150262108 | 1.75 |
Fry |
FRY microtubule binding protein |
1796 |
0.34 |
chr1_72873040_72873227 | 1.72 |
Igfbp5 |
insulin-like growth factor binding protein 5 |
1142 |
0.54 |
chr15_103026302_103028215 | 1.72 |
Hoxc4 |
homeobox C4 |
7137 |
0.09 |
chr7_109670395_109670546 | 1.72 |
Denn2b |
DENN domain containing 2B |
1616 |
0.3 |
chr16_38364563_38365451 | 1.70 |
Popdc2 |
popeye domain containing 2 |
2762 |
0.17 |
chr12_8244605_8244797 | 1.70 |
Ldah |
lipid droplet associated hydrolase |
23662 |
0.15 |
chr13_89929582_89929846 | 1.70 |
Gm24498 |
predicted gene, 24498 |
2171 |
0.43 |
chr7_36710059_36710756 | 1.68 |
Gm37452 |
predicted gene, 37452 |
233 |
0.9 |
chr10_92162169_92163486 | 1.68 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
66 |
0.98 |
chr15_51104066_51105013 | 1.68 |
Gm48913 |
predicted gene, 48913 |
206900 |
0.02 |
chr2_52720638_52720837 | 1.68 |
Gm13548 |
predicted gene 13548 |
18718 |
0.18 |
chr5_17576028_17576427 | 1.68 |
Sema3c |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
1328 |
0.57 |
chr7_89405888_89406433 | 1.67 |
Fzd4 |
frizzled class receptor 4 |
1805 |
0.24 |
chr2_92140355_92141595 | 1.67 |
Phf21a |
PHD finger protein 21A |
43131 |
0.11 |
chr5_23224759_23225324 | 1.67 |
Gm42948 |
predicted gene 42948 |
1245 |
0.52 |
chr11_19008700_19009431 | 1.67 |
Gm16140 |
predicted gene 16140 |
63 |
0.96 |
chr15_27786588_27788615 | 1.66 |
Trio |
triple functional domain (PTPRF interacting) |
1037 |
0.6 |
chr13_115346333_115347310 | 1.66 |
Gm47891 |
predicted gene, 47891 |
64620 |
0.13 |
chr9_89496526_89496946 | 1.65 |
Gm47403 |
predicted gene, 47403 |
63648 |
0.11 |
chr1_135257446_135257838 | 1.65 |
Elf3 |
E74-like factor 3 |
7 |
0.96 |
chr6_53574522_53574673 | 1.64 |
Creb5 |
cAMP responsive element binding protein 5 |
1221 |
0.6 |
chrX_147552812_147553925 | 1.64 |
Lrch2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
682 |
0.76 |
chr14_22168600_22169219 | 1.64 |
Gm7480 |
predicted gene 7480 |
132806 |
0.04 |
chr15_99056560_99057587 | 1.64 |
Prph |
peripherin |
1103 |
0.3 |
chr2_137107794_137108485 | 1.64 |
Jag1 |
jagged 1 |
8505 |
0.28 |
chrX_88115387_88116599 | 1.63 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
348 |
0.92 |
chr17_18916089_18916240 | 1.63 |
Vmn2r97 |
vomeronasal 2, receptor 97 |
1864 |
0.43 |
chr18_84070282_84070920 | 1.63 |
Tshz1 |
teashirt zinc finger family member 1 |
14474 |
0.16 |
chr5_57723598_57724600 | 1.63 |
Gm42635 |
predicted gene 42635 |
294 |
0.83 |
chr16_73530171_73530440 | 1.63 |
Gm49680 |
predicted gene, 49680 |
45448 |
0.16 |
chr1_188008080_188008231 | 1.62 |
9330162B11Rik |
RIKEN cDNA 9330162B11 gene |
835 |
0.69 |
chr5_21543417_21545108 | 1.62 |
Lrrc17 |
leucine rich repeat containing 17 |
699 |
0.68 |
chr3_110022906_110023531 | 1.62 |
Ntng1 |
netrin G1 |
112250 |
0.06 |
chr16_22549213_22549379 | 1.62 |
Gm15651 |
predicted gene 15651 |
743 |
0.52 |
chr6_135362982_135365483 | 1.61 |
Emp1 |
epithelial membrane protein 1 |
1164 |
0.42 |
chr2_136054231_136054575 | 1.61 |
Lamp5 |
lysosomal-associated membrane protein family, member 5 |
2164 |
0.34 |
chr3_97823312_97824263 | 1.60 |
Pde4dip |
phosphodiesterase 4D interacting protein (myomegalin) |
834 |
0.65 |
chr5_5708100_5708698 | 1.60 |
Gm43219 |
predicted gene 43219 |
11541 |
0.15 |
chr11_30265934_30266417 | 1.60 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
1039 |
0.45 |
chr11_19011176_19011795 | 1.60 |
Meis1 |
Meis homeobox 1 |
517 |
0.67 |
chr10_38967267_38967717 | 1.60 |
Lama4 |
laminin, alpha 4 |
1820 |
0.42 |
chr6_4005760_4006960 | 1.60 |
Gng11 |
guanine nucleotide binding protein (G protein), gamma 11 |
2456 |
0.24 |
chr17_43758947_43759124 | 1.60 |
Cyp39a1 |
cytochrome P450, family 39, subfamily a, polypeptide 1 |
27092 |
0.17 |
chr13_107207479_107208489 | 1.58 |
Gm2726 |
predicted gene 2726 |
72207 |
0.1 |
chr18_57545680_57545862 | 1.58 |
4930511M06Rik |
RIKEN cDNA 4930511M06 gene |
6005 |
0.17 |
chr15_103058659_103059955 | 1.58 |
5730585A16Rik |
RIKEN cDNA 5730585A16 gene |
1 |
0.95 |
chr2_74752572_74753602 | 1.57 |
Haglr |
Hoxd antisense growth associated long non-coding RNA |
360 |
0.42 |
chr7_37342624_37344008 | 1.57 |
6720469O03Rik |
RIKEN cDNA 6720469O03 gene |
23314 |
0.21 |
chr4_102256022_102256825 | 1.57 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
1193 |
0.63 |
chr3_30207576_30208234 | 1.57 |
Gm38197 |
predicted gene, 38197 |
19789 |
0.16 |
chr5_69338848_69339239 | 1.57 |
Gm24368 |
predicted gene, 24368 |
1740 |
0.27 |
chr4_143298537_143299593 | 1.57 |
Pdpn |
podoplanin |
398 |
0.83 |
chr3_79737622_79737909 | 1.57 |
Rxfp1 |
relaxin/insulin-like family peptide receptor 1 |
29 |
0.98 |
chr14_48324291_48324442 | 1.57 |
1700128I11Rik |
RIKEN cDNA 1700128I11 gene |
38249 |
0.12 |
chr17_3610552_3611747 | 1.57 |
1700102H20Rik |
RIKEN cDNA 1700102H20 gene |
53280 |
0.12 |
chr5_111054620_111054921 | 1.56 |
Gm42780 |
predicted gene 42780 |
26218 |
0.15 |
chr15_102998261_102998699 | 1.56 |
Hoxc6 |
homeobox C6 |
223 |
0.84 |
chr10_91249578_91250191 | 1.56 |
Gm18705 |
predicted gene, 18705 |
9460 |
0.17 |
chr14_84449148_84450009 | 1.56 |
Pcdh17 |
protocadherin 17 |
1071 |
0.59 |
chr7_16879901_16880548 | 1.56 |
Dact3 |
dishevelled-binding antagonist of beta-catenin 3 |
4907 |
0.09 |
chr8_12947702_12949640 | 1.55 |
Mcf2l |
mcf.2 transforming sequence-like |
718 |
0.37 |
chr9_76506986_76507163 | 1.55 |
Fam83b |
family with sequence similarity 83, member B |
38730 |
0.19 |
chr5_66968814_66970199 | 1.54 |
Gm43282 |
predicted gene 43282 |
77 |
0.88 |
chr11_86472817_86473930 | 1.54 |
Rnft1 |
ring finger protein, transmembrane 1 |
11284 |
0.16 |
chr1_119458031_119458388 | 1.54 |
Ralb |
v-ral simian leukemia viral oncogene B |
19870 |
0.14 |
chr9_57803223_57803374 | 1.53 |
Arid3b |
AT rich interactive domain 3B (BRIGHT-like) |
7077 |
0.16 |
chr1_82267288_82267654 | 1.53 |
Irs1 |
insulin receptor substrate 1 |
23945 |
0.16 |
chr6_52181680_52182035 | 1.53 |
Gm29430 |
predicted gene 29430 |
1253 |
0.16 |
chr5_92811720_92812319 | 1.52 |
Shroom3 |
shroom family member 3 |
2549 |
0.29 |
chr2_57613223_57613600 | 1.52 |
Gm13532 |
predicted gene 13532 |
15817 |
0.2 |
chr3_38894285_38895428 | 1.51 |
Fat4 |
FAT atypical cadherin 4 |
3914 |
0.27 |
chr13_83747532_83747683 | 1.51 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
8744 |
0.13 |
chr1_82586379_82587667 | 1.51 |
Col4a3 |
collagen, type IV, alpha 3 |
47 |
0.67 |
chr2_61283959_61284511 | 1.51 |
Gm26422 |
predicted gene, 26422 |
3957 |
0.32 |
chr14_61257948_61258209 | 1.50 |
Sgcg |
sarcoglycan, gamma (dystrophin-associated glycoprotein) |
346 |
0.85 |
chr8_8994404_8995384 | 1.50 |
Gm44515 |
predicted gene 44515 |
62195 |
0.12 |
chr9_59189343_59189641 | 1.50 |
Gm7589 |
predicted gene 7589 |
43282 |
0.15 |
chr2_9874123_9875699 | 1.50 |
Gata3 |
GATA binding protein 3 |
488 |
0.68 |
chr8_74871836_74872493 | 1.50 |
Isx |
intestine specific homeobox |
1009 |
0.61 |
chr11_96294128_96295421 | 1.49 |
Hoxb6 |
homeobox B6 |
2298 |
0.11 |
chr17_10314038_10315183 | 1.49 |
Qk |
quaking |
4751 |
0.26 |
chr18_4137682_4137958 | 1.48 |
Lyzl1 |
lysozyme-like 1 |
28012 |
0.19 |
chr16_63863108_63864179 | 1.48 |
Epha3 |
Eph receptor A3 |
230 |
0.96 |
chr8_24351673_24352600 | 1.47 |
Gm45164 |
predicted gene 45164 |
7300 |
0.22 |
chr5_138271764_138273195 | 1.47 |
Gal3st4 |
galactose-3-O-sulfotransferase 4 |
270 |
0.76 |
chr13_40727690_40728914 | 1.47 |
Gm26688 |
predicted gene, 26688 |
494 |
0.48 |
chr4_141422660_141422953 | 1.46 |
Hspb7 |
heat shock protein family, member 7 (cardiovascular) |
2027 |
0.17 |
chr18_74966819_74967388 | 1.46 |
Lipg |
lipase, endothelial |
5840 |
0.1 |
chr14_111680945_111682200 | 1.46 |
Slitrk5 |
SLIT and NTRK-like family, member 5 |
5723 |
0.23 |
chr2_164400211_164401393 | 1.46 |
Rbpjl |
recombination signal binding protein for immunoglobulin kappa J region-like |
2339 |
0.15 |
chr3_60529662_60530216 | 1.46 |
Mbnl1 |
muscleblind like splicing factor 1 |
308 |
0.91 |
chr2_105243064_105243215 | 1.46 |
Them7 |
thioesterase superfamily member 7 |
18797 |
0.22 |
chr13_89541543_89541900 | 1.46 |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
1925 |
0.42 |
chr14_110753664_110754027 | 1.46 |
Slitrk6 |
SLIT and NTRK-like family, member 6 |
1304 |
0.42 |
chr3_24782863_24783977 | 1.45 |
Naaladl2 |
N-acetylated alpha-linked acidic dipeptidase-like 2 |
202 |
0.97 |
chr16_6840364_6841436 | 1.45 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
31678 |
0.26 |
chr6_52174920_52176658 | 1.44 |
Hoxaas3 |
Hoxa cluster antisense RNA 3 |
554 |
0.41 |
chr10_18470218_18471289 | 1.44 |
Nhsl1 |
NHS-like 1 |
772 |
0.72 |
chr2_169621071_169621803 | 1.43 |
Gm34294 |
predicted gene, 34294 |
6881 |
0.21 |
chr12_53768607_53769006 | 1.43 |
1700060O08Rik |
RIKEN cDNA 1700060O08 gene |
310586 |
0.01 |
chr2_64094606_64096009 | 1.43 |
Fign |
fidgetin |
2681 |
0.44 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 12.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
2.7 | 10.7 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.9 | 1.9 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.5 | 3.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.5 | 4.4 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
1.3 | 3.9 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.2 | 2.5 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.2 | 2.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.1 | 3.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.0 | 4.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.0 | 5.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.0 | 2.0 | GO:0060435 | bronchiole development(GO:0060435) |
1.0 | 2.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.8 | 2.5 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.8 | 3.8 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.7 | 4.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.6 | 1.3 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.6 | 1.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.6 | 2.5 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.6 | 1.8 | GO:0060618 | nipple development(GO:0060618) |
0.6 | 3.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.6 | 1.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.6 | 1.2 | GO:0035799 | ureter maturation(GO:0035799) |
0.6 | 0.6 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.6 | 1.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.6 | 1.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.6 | 2.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 1.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.6 | 0.6 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.6 | 0.6 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.5 | 1.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 4.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.5 | 1.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 6.0 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.5 | 1.0 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.5 | 1.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.5 | 3.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.5 | 2.3 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.5 | 0.9 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.5 | 1.4 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.4 | 3.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.4 | 1.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.4 | 1.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 2.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 1.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.4 | 0.4 | GO:1900200 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
0.4 | 0.8 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.4 | 2.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.4 | 2.0 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.4 | 2.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 1.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.4 | 1.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.4 | 2.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 0.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 0.4 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.4 | 0.4 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
0.4 | 2.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 1.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 | 1.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.4 | 0.7 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.4 | 1.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 1.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.4 | 1.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.4 | 1.1 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.3 | 2.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 | 0.7 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.3 | 1.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 1.3 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.3 | 1.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 2.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.3 | 0.6 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 1.3 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 0.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 0.6 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.3 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 | 0.3 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 0.9 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.3 | 1.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.3 | 0.9 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.3 | 0.9 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.3 | 0.6 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.3 | 0.9 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.3 | 0.6 | GO:0060596 | mammary placode formation(GO:0060596) |
0.3 | 2.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.3 | 1.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 0.8 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.3 | 0.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 0.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.3 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 0.3 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.3 | 2.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.3 | 0.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 1.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.3 | 1.1 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.3 | 2.9 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 1.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 0.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 0.8 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.3 | 0.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.3 | 0.3 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.3 | 1.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 1.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 0.8 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.3 | 1.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.3 | 0.5 | GO:0048880 | sensory system development(GO:0048880) |
0.3 | 22.8 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.2 | 0.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.7 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 2.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.2 | 2.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 0.5 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 1.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 0.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 1.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.5 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 0.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.2 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 0.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.9 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 1.1 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 2.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.2 | 0.7 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.2 | 0.9 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 0.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 1.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 0.4 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.2 | 0.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 3.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 1.1 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 2.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.2 | 1.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 0.8 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.2 | 0.6 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 0.4 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.2 | 2.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 0.8 | GO:0044849 | estrous cycle(GO:0044849) |
0.2 | 0.4 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.8 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.2 | 0.4 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.2 | 0.4 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.6 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.2 | 1.1 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.2 | 0.4 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.2 | 0.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.4 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.2 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 1.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.2 | 0.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.7 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 0.5 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.4 | GO:0090427 | activation of meiosis(GO:0090427) |
0.2 | 0.5 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 0.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 2.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.2 | 0.5 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.2 | 0.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 1.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 0.5 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.2 | 0.2 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.2 | 1.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 0.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 1.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 2.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 1.3 | GO:0043586 | tongue development(GO:0043586) |
0.2 | 0.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.2 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.2 | 1.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 1.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.8 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 0.3 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.2 | 0.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.2 | 0.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 1.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 3.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 0.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.2 | 0.8 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.2 | 1.7 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.2 | 0.9 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 0.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.5 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.2 | 0.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.8 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.2 | 0.5 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.9 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 0.4 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.1 | 0.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.1 | 1.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.6 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 1.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 1.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.1 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
0.1 | 0.3 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.3 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.1 | 0.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.1 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.1 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.4 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.1 | 0.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.1 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.3 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.5 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.3 | GO:0003150 | membranous septum morphogenesis(GO:0003149) muscular septum morphogenesis(GO:0003150) |
0.1 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 6.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.6 | GO:0007619 | courtship behavior(GO:0007619) |
0.1 | 0.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.7 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.1 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.1 | 2.8 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.4 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.7 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.1 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.1 | 0.2 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.1 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.4 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.6 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.8 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.2 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.1 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.1 | 0.1 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.1 | 0.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.9 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.1 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.1 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.2 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.4 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.3 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.1 | 0.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.2 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 0.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.3 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.1 | 0.4 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.1 | 0.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.1 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.2 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.1 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.1 | GO:0051794 | regulation of catagen(GO:0051794) |
0.1 | 0.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 1.1 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.3 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 1.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.4 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.1 | 0.4 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 0.4 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.8 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.2 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.3 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.1 | 0.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.8 | GO:0003401 | axis elongation(GO:0003401) |
0.1 | 0.5 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.1 | 1.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.1 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.1 | 0.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.2 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 1.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 3.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.2 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.1 | 0.2 | GO:0032835 | glomerulus development(GO:0032835) |
0.1 | 1.6 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.1 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.1 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.4 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.1 | 0.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.5 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.4 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.2 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.3 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.1 | GO:0035932 | renin-angiotensin regulation of aldosterone production(GO:0002018) mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.1 | 0.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 1.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.1 | 0.1 | GO:0003128 | heart field specification(GO:0003128) |
0.1 | 2.7 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.3 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.1 | 0.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 1.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.8 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.1 | 0.5 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.1 | 0.2 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.1 | 0.8 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.3 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 1.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.1 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.1 | 0.2 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.1 | 0.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 1.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.2 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.1 | 0.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 0.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.7 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.1 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.3 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.5 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.4 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.3 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 0.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.1 | GO:0042363 | vitamin catabolic process(GO:0009111) diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 1.0 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.3 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.1 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 0.1 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 1.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.4 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.6 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.3 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 0.6 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.2 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.1 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.1 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.1 | 0.1 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.1 | 1.2 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.1 | 0.3 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 0.2 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.1 | 0.3 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.6 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.1 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.6 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.3 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.1 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.1 | 0.6 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 1.3 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.4 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.1 | 0.6 | GO:0061005 | cell differentiation involved in kidney development(GO:0061005) |
0.1 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.2 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.3 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.1 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.1 | 0.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.2 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.1 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.1 | 0.1 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.1 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.1 | 0.1 | GO:1903423 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 1.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.3 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.5 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.4 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 1.3 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.4 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.2 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.1 | GO:0035793 | cell migration involved in kidney development(GO:0035787) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.1 | 0.3 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.2 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.1 | GO:2001054 | regulation of mesenchymal cell apoptotic process(GO:2001053) negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 0.1 | GO:0050942 | positive regulation of developmental pigmentation(GO:0048087) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.2 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.1 | 0.1 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.1 | 0.2 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 0.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.1 | 0.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.7 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.2 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.3 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.1 | 2.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 4.7 | GO:0006936 | muscle contraction(GO:0006936) |
0.1 | 0.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.3 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.4 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.2 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.0 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.0 | 0.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.0 | 0.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.3 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.1 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.0 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.0 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.1 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.0 | 0.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.1 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.6 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.0 | 0.1 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.0 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.0 | 0.4 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.2 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.7 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.0 | 0.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.0 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.0 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.0 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.0 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.1 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.0 | GO:0098901 | regulation of cardiac muscle cell action potential(GO:0098901) |
0.0 | 0.0 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.0 | 0.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.0 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.1 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.0 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.0 | 0.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.7 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.3 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.0 | 0.0 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) |
0.0 | 0.3 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.0 | 0.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 0.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.2 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.0 | 0.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.2 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 1.7 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.0 | 0.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.1 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.0 | 0.3 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.0 | 0.9 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.0 | 0.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.0 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.0 | 0.2 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.2 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.0 | 0.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.0 | 0.5 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.2 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.0 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.0 | 0.0 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.0 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.0 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.0 | 0.0 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.0 | 0.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.0 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.0 | 0.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.1 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.0 | 0.0 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.0 | 0.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.2 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.1 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.1 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.0 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.0 | 0.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.0 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.0 | 0.0 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.0 | 0.0 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.0 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.0 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.0 | 0.0 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.0 | 0.2 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.0 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.0 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.0 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.0 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.0 | 0.2 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.0 | 0.0 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.0 | 0.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.0 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.0 | 0.0 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.0 | 0.0 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.1 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.0 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.0 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.0 | 0.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.0 | 0.0 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.0 | 0.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.0 | 0.0 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.0 | 0.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.0 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.0 | 0.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.6 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.4 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.0 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.0 | 0.0 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 0.0 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.0 | 0.0 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.0 | 0.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.0 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 0.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.0 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.0 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.0 | 0.0 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 | 0.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.3 | GO:0035108 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.0 | 0.0 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.0 | GO:0001705 | ectoderm formation(GO:0001705) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.1 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.0 | 0.0 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.1 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.0 | 0.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.0 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.0 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.0 | 0.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.0 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.0 | 0.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 0.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.0 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.0 | 0.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.0 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.0 | GO:2001026 | regulation of endothelial cell chemotaxis(GO:2001026) |
0.0 | 0.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.3 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 2.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 1.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 1.6 | GO:1990696 | USH2 complex(GO:1990696) |
0.4 | 1.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 2.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 5.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 5.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 1.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 0.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 1.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 3.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 2.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 1.0 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 1.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 7.6 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 0.7 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 2.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 1.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 1.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.2 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.2 | 2.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 1.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.2 | 0.7 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 0.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 0.4 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 1.4 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 0.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 0.7 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 1.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 0.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.7 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.3 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.2 | 0.5 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 0.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 2.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 2.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.5 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 1.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.9 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 1.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 1.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 1.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 2.1 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 2.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 1.4 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 3.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.8 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 1.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.6 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 1.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.2 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 1.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 1.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 3.8 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 1.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 14.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 4.9 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 1.0 | GO:0031674 | I band(GO:0031674) |
0.1 | 1.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 2.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 1.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.3 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 1.1 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 1.6 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 1.2 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 1.9 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.5 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 7.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.6 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 0.4 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 2.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 3.9 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 1.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 1.5 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 1.1 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 4.0 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 1.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.2 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.0 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 4.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.7 | 0.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 2.7 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.5 | 1.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.5 | 4.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.5 | 1.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.5 | 3.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 1.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.4 | 1.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.4 | 2.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 0.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.4 | 2.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.4 | 1.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.4 | 1.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.4 | 1.9 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 3.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.4 | 2.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 2.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 2.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 2.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 3.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 3.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 2.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 1.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 0.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 7.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.3 | 0.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 1.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 0.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 3.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 1.6 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.3 | 0.3 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 1.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 0.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 0.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 1.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 1.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.8 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.2 | 2.5 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.8 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 0.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 1.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 1.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 6.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 0.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 3.3 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 2.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 0.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 1.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 1.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.8 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 0.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 0.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 0.6 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 2.0 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 1.1 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 4.3 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 1.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 4.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 7.3 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 1.4 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 1.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 1.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 1.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 0.4 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 1.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 9.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 1.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.8 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 2.8 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 1.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 0.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.6 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 1.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 1.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 1.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 1.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 1.7 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.2 | GO:0034920 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 1.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 3.6 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 1.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.3 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 1.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 6.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 1.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 2.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.1 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 0.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 1.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.6 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.9 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 46.4 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.5 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.1 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 1.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 2.2 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.1 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.0 | 0.2 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.0 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 1.8 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.8 | GO:0052867 | JUN kinase phosphatase activity(GO:0008579) phosphohistidine phosphatase activity(GO:0008969) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) NADP phosphatase activity(GO:0019178) transmembrane receptor protein phosphatase activity(GO:0019198) 5-amino-6-(5-phosphoribitylamino)uracil phosphatase activity(GO:0043726) phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) phosphatidylinositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052867) IDP phosphatase activity(GO:1990003) |
0.0 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.2 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 1.0 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.0 | 0.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 2.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.1 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.0 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.2 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.4 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.0 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 2.1 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 1.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.5 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.8 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.0 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 2.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 8.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 3.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 2.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 5.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 4.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 4.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 3.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 3.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 3.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 13.2 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 1.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 3.2 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 2.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 8.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 1.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 8.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.6 | 0.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 7.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 5.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 4.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.3 | 3.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 5.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 2.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 3.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 2.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 0.6 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 0.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 6.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 3.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.6 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 2.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 2.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 2.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 2.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 1.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 1.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 2.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 7.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 2.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 2.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 2.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.5 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 0.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 6.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.2 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 9.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.4 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 1.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.5 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.1 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |